Patients with B-ALL harbor many genetic alterations in transcription factors including chromosomal rearrangements, deletions, or inactivating mutations in DUX4, PAX5, IKZF1, and TCF3, among others (10). This evidence concerns the gene DUX4 and acute lymphoblastic leukemia.